Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
06/03/1992 | CN1061595A Heterocyclic compounds ad antagonists of excitatory amino acid receptors, processes for their preparation and their use |
06/03/1992 | CN1061594A Hydroxyalkylquineline ether acids as leakotaiene antagonists |
06/03/1992 | CN1016872B Bcd tricyclic ergoline part-structure analoguse |
06/02/1992 | US5118806 Enzyme inhibitor for lipoxygenase; useful for treating cancer, hepatic diseases, inflammation, cerebrovascular diseases |
06/02/1992 | US5118701 Antiischemic agents, anticoagulants |
06/02/1992 | US5118694 Benzopyran derivatives |
06/02/1992 | US5118689 Antiarrhythmia agents |
06/02/1992 | US5118687 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing same |
06/02/1992 | US5118686 Phenylpyrimidones |
06/02/1992 | US5118685 Aminopropanol derivatives of substituted 2-hydroxy-propiophenones, and therapeutic agents containing these compounds |
06/02/1992 | US5118682 P-hydroxy phenone derivatives and the use thereof |
06/02/1992 | US5118668 Peptide having sequence of appotinin where in one or more amino acids are replaced at position 15,16,17,18 34-39 and 52. by naturally occuring amino acid useful for hyperfibrinolytic or traumatic hemorrhage |
06/02/1992 | US5118505 Ginkge extract and folic, lipoic and(or) vitamin b |
06/02/1992 | CA1302425C Prodrugs of antihypercholesterolemic compounds |
06/02/1992 | CA1302409C Benzazepine derivatives |
06/02/1992 | CA1302405C Ergoline derivatives |
06/02/1992 | CA1302268C Pharmaceutical compositions containing diltiazem and an enzyme inhibitor |
05/30/1992 | CA2056560A1 Guanidine derivates, the process for the preparation thereof and the pharmaceutical compositions containing them |
05/30/1992 | CA2056032A1 Hard capsule preparation |
05/29/1992 | WO1992009582A1 Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation |
05/29/1992 | WO1992008708A1 Biologically active amines |
05/29/1992 | WO1992008694A1 Aminosulfonyl urea acat inhibitors |
05/29/1992 | WO1992008693A1 Aminosulfonyl carbamates |
05/29/1992 | WO1992008692A1 Oxysulfonyl urea acat inhibitors |
05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
05/29/1992 | WO1992008473A1 Therapeutic use of fibroblast growth factor |
05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
05/29/1992 | CA2094807A1 Aminosulfonyl carbamates |
05/29/1992 | CA2074729A1 Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation |
05/27/1992 | EP0487423A1 Benzoselenazolinone derivatives, their preparation and pharmaceutical compositions containing them |
05/27/1992 | EP0487410A2 Endothelin antagonists |
05/27/1992 | EP0487382A1 Use of buflomedil for the protection of the myocardium by coronary angioplasty |
05/27/1992 | EP0487252A1 Quinoline and 1,5-Naphthyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
05/27/1992 | EP0486882A1 Substituted anilides |
05/27/1992 | EP0486809A2 Use of suramin against TNF-related diseases |
05/27/1992 | DE4037941A1 Cyclopentanetherderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Cyclopentanetherderivate, processes for their preparation and their pharmaceutical use |
05/27/1992 | DE4037174A1 Neue sulfonamide, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten New sulfonamides, process for their production and pharmaceuticals containing these compounds |
05/27/1992 | CN1061413A Pharmaceutical compounds |
05/27/1992 | CN1061410A Substituted azoles, process for their preparation, agents containing them and their use |
05/27/1992 | CN1061407A Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
05/27/1992 | CA2054638A1 Benzodiazolo analogs |
05/26/1992 | US5116986 Heteroaromatic amine derivatives |
05/26/1992 | US5116974 3-carbalkoxyamino-5-aminoacyl-5H-dibenz[b,f]azepines, and methods for making |
05/26/1992 | US5116964 Hybrid immunoglobulins |
05/26/1992 | US5116878 Medicinal composition for the treatment and prevention of the symptoms of heart failure, containing a vasoconstrictor alpha-stimulant agent as active principle |
05/26/1992 | US5116871 Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis |
05/26/1992 | US5116856 Aminoethylthiazole and aminoethyloxazole derivatives |
05/26/1992 | US5116851 Pharmaceutical composition and method for treating cardiovascular diseases using substituted anilides and sulfonamides |
05/26/1992 | US5116849 4-amidino chroman and 4-amidino pyrano (3,2-c) pyridine derivatives, a process for their preparation and pharmaceutical compositions containing them |
05/26/1992 | US5116848 N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents |
05/26/1992 | US5116837 2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines |
05/26/1992 | US5116835 Enzyme-inhibiting urea derivatives of dipeptides, a process for the preparation thereof, agents containing these, and the use thereof |
05/26/1992 | US5116617 Pharmaceutical composition for topical use in the treatment of the capillary fragility |
05/26/1992 | CA1302005C Aminoacid derivatives as antihypertensives |
05/26/1992 | CA1301770C Isothiuronium salts |
05/26/1992 | CA1301759C Pyranopyridines having antihypertensive activity |
05/26/1992 | CA1301652C Continuous intravenous infusion of adenosine to human patients |
05/25/1992 | CA2056063A1 Aminodiol derivatives |
05/24/1992 | WO1992009573A2 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
05/24/1992 | CA2096848A1 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
05/24/1992 | CA2056008A1 Benzoselenazolinone derivatives; process for preparing the same and pharmaceutical compositions containing them |
05/23/1992 | WO1992009571A1 Medicaments containing sulphonamides, novel sulphonamides and proces for producing them |
05/23/1992 | CA2096847A1 Pharmaceutical preparations containing sulfonamides novel sulfonamides and processes for their production |
05/22/1992 | WO1992009556A1 Improved matrix metalloprotease inhibitors |
05/22/1992 | CA2096221A1 Matrix metalloprotease inhibitors |
05/22/1992 | CA2055902A1 Peptide derivatives, their preparation process, application of these new derivatives as drugs and pharmaceutical compositions containing them |
05/20/1992 | EP0486478A2 Renin-inhibiting peptides |
05/20/1992 | EP0486386A2 Novel derivatives of N-benzoylproline, process for their preparation and drugs containing them |
05/20/1992 | EP0486385A1 Imidazole derivatives, process for their fabrication and pharmaceutical compositions containing them |
05/20/1992 | EP0486001A1 Recombinant urinary trypsin inhibitor fragments and drug composition |
05/20/1992 | EP0485962A2 New tricyclic compounds |
05/20/1992 | EP0485961A1 Oncostatin M for stimulating LDL uptake and LDL receptor expression |
05/20/1992 | EP0485929A1 Substituted azoles, process for their preparation and their application |
05/20/1992 | EP0485748A2 Salts of glycosaminoglycans with esters of aminoacids, preparation thereof and pharmaceutical formulations containing them |
05/20/1992 | EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
05/20/1992 | CN1061224A Indole-and benzimidazole-substitued imidazole and benzimidazole derivatives |
05/20/1992 | CN1061152A Ester inhibitors |
05/20/1992 | CA2054555A1 Nitrogen compounds |
05/19/1992 | US5114966 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(rs)-substituted, useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties |
05/19/1992 | US5114952 Isoquinolinylsulfonamides as anti-arrhythmic agents |
05/19/1992 | US5114941 Pyrimidinedione derivative compounds, method for preparing same, and antiarrythmic agents containing same |
05/19/1992 | US5114927 Hypotensive agents and inhibiting renin |
05/19/1992 | US5114916 Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants |
05/19/1992 | CA1301183C2 Aralykyl (arylethynyl) aralkyl amines and their use as vasodilators and antihypertensives |
05/19/1992 | CA1301174C Substituted 1h-imidazoles |
05/19/1992 | CA1301171C 1,12b-disubstituted octahydroindolo ¬2,3-a| quinolizine derivatives, process for their preparation and pharmaceutical compositions containing them |
05/18/1992 | CA2055689A1 Substituted anilides |
05/17/1992 | CA2055680A1 Tricyclic compounds |
05/17/1992 | CA2055636A1 Substituted azoles, process for their preparation, agents containing them and their use |
05/16/1992 | WO1992008724A1 New heterocyclic compounds as antagonists of excitatory amino acid receptors, processes for their preparation and their use |
05/16/1992 | WO1992008453A1 Hydroxamic acids for preventing reperfusion injury |
05/16/1992 | CA2095606A1 Hydroxamic acids for preventing reperfusion injury |
05/16/1992 | CA2095224A1 Heterocyclic compounds as antagonists of excitatory amino acid receptors, processes for their preparation and their use |
05/15/1992 | WO1992008705A1 5-fluoro-2,4,6-pyrimidinetriamine compounds |
05/15/1992 | WO1992008482A1 Compositions for reducing oxidative injury |
05/15/1992 | CA2096333A1 Compositions for reducing oxidative injury |
05/15/1992 | CA2092811A1 5-fluoro-2,4,6-pyrimidinetriamine compounds |
05/15/1992 | CA2055326A1 N-benzoylproline derivatives, a process for their preparation and pharmaceutical compositions holding same |
05/15/1992 | CA2055325A1 Novel imidazole derivatives, process for preparing them and pharmaceutical compositions containing them |
05/14/1992 | WO1992007937A1 Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides |